| 2022 | | Healthcare resource utilization in patients treated with empagliflozin in East Asia | 김대중, 하경화 |
| 2000 | | HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. | 김현만, 정윤석 |
| 2019 | | Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study | 이관우 |
| 2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study | 김대중, 김혜진, 문소영, 이관우, 전자영, 한승진 |
| 2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125-33) | 한승진 |
| 2016 | | Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: An analysis based on the Korea National Diabetes Program Cohort | 이관우, 전기홍 |
| 2024 | | Imeglimin attenuates NLRP3 inflammasome activation by restoring mitochondrial functions in macrophages | 김대중, 김혜진, 이관우, 전자영, 한승진 |
| 2017 | | Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies | 김대중, 이광재 |
| 2016 | | Increased postprandial apolipoprotein B-48 level after a test meal in diabetic patients: A multicenter, cross-sectional study | 김대중 |
| 2015 | | Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension. | 이관우 |
| 2018 | | Long-term effects on glycaemic control and beta-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial | 이관우 |
| 2018 | | Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort | 김대중, 김혜진, 이관우, 전기홍, 전자영, 한승진 |
| 2005 | | Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus. | 김대중 |
| 2016 | | Psychometric Evaluation of a Korean Version of the Adherence to Refills and Medications Scale (ARMS) in Adults With Type 2 Diabetes | 김대중, 김춘자 |
| 2016 | | Risk factors of severe hypoglycemia requiring medical assistance and neurological sequelae in patients with diabetes: A case-control study | 김대중, 김혜진, 이관우, 전자영, 한승진 |
| 2021 | | Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study | 정윤석 |
| 2019 | | Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study | 김대중, 하경화 |
| 2006 | | The 11482G >A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes. | 김혜진 |
| 2007 | | The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats. | 김대중 |
| 2007 | | The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment. | 김혜진 |
| 2006 | | The long-term effects of rosiglitazone on serum lipid concentrations and body weight. | 김혜진 |
| 2015 | | The role of social support on the relationship of depressive symptoms to medication adherence and self-care activities in adults with type 2 diabetes. | 김대중, 김춘자 |
| 2016 | | Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study | 김대중 |
| 2019 | | Utilization patterns of insulin for patients with type 2 diabetes from national health insurance claims data in South Korea | 김대중 |
